Anti-factor xa activity of standard and Japan-specific doses of rivaroxaban in thai patients with non-valvular atrial fibrillation
© 2020 Japanese Circulation Society. All rights reserved. Background: Recommended rivaroxaban doses for stroke prevention in atrial fibrillation (SPAF) are 20 and 15 mg/day in patients with normal and reduced renal function, respectively, but lower doses (15 and 10 mg) have been tested and approved...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | 雜誌 |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087111274&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70833 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| 機構: | Chiang Mai University |